Carey Ng
Director/Board Member bei IMMIX BIOPHARMA, INC.
Vermögen: 3 Mio $ am 31.03.2024
Profil
Carey J.
Ng is currently the Managing Director at Mesa Verde Ventures LLC since 2013.
Additionally, Dr. Ng holds the position of Director at Satiogen Pharmaceuticals, Inc., Director at Elysium Therapeutics, Inc., and Independent Director at Immix Biopharma, Inc. since 2019.
Previously, Dr. Ng served as Director at Paradigm Diagnostics, Inc. and Director at Biscayne Neurotherapeutics, Inc. Dr. Ng obtained a doctorate degree from the University of California, Los Angeles in 2004.
Furthermore, Dr. Ng holds an MBA from the University of California San Diego and an MBA from the University of California, conferred in 2008.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
IMMIX BIOPHARMA, INC.
4,05% | 14.09.2023 | 1 035 221 ( 4,05% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Carey Ng
Unternehmen | Position | Beginn |
---|---|---|
IMMIX BIOPHARMA, INC. | Director/Board Member | 01.11.2019 |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Director/Board Member | - |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Private Equity Investor | 01.01.2008 |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Director/Board Member | - |
Ehemalige bekannte Positionen von Carey Ng
Unternehmen | Position | Ende |
---|---|---|
Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Paradigm Diagnostics, Inc. develops, manufactures and distributes high throughput microbiological screening tests. It has developed and is currently selling diagnostic tests to the food processing industry that allow them to screen environmental samples for pathogens in- house. The company was founded by Alan D. Olstein in 2001 and is headquartered in St. Paul, MN. | Director/Board Member | - |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Biscayne Neurotherapeutics, Inc. engages in the development of novel treatments for epilepsy, pain and other central nervous system (CNS) disorders. The company was founded by Samuel J. Reich on November 15, 2011 and is headquartered in Miami, FL. | Director/Board Member | - |
Ausbildung von Carey Ng
University of California, Los Angeles | Doctorate Degree |
University of California | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IMMIX BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Paradigm Diagnostics, Inc.
Paradigm Diagnostics, Inc. Medical SpecialtiesHealth Technology Paradigm Diagnostics, Inc. develops, manufactures and distributes high throughput microbiological screening tests. It has developed and is currently selling diagnostic tests to the food processing industry that allow them to screen environmental samples for pathogens in- house. The company was founded by Alan D. Olstein in 2001 and is headquartered in St. Paul, MN. | Health Technology |
Mesa Verde Ventures LLC
Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Finance |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Commercial Services |
Biscayne Neurotherapeutics, Inc.
Biscayne Neurotherapeutics, Inc. BiotechnologyHealth Technology Biscayne Neurotherapeutics, Inc. engages in the development of novel treatments for epilepsy, pain and other central nervous system (CNS) disorders. The company was founded by Samuel J. Reich on November 15, 2011 and is headquartered in Miami, FL. | Health Technology |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH. | Health Technology |